AI
The model showed 86% sensitivity and a specificity of up to 96.1%.
The technology can detect 588 common and rare skin conditions in 133 categories.
The partnership will use Ada Health's AI-based platform to speed up the diagnosis of rare conditions.
Rutherford Health Chief Medical Officer Karol Sikora highlights the most pressing needs in cancer treatment today and how he envisages treatment decision-making in the next decade.
The partnership will work on a drug discovery programme for the genetic muscle wasting disorder.
The company states that the study was designed to minimise bias in assessing the solution’s impact on diagnostic accuracy.
According to the Hong Kong-based startup, the SenseCare-Chest DR Pro can quickly identify normal and abnormal scans from chest x-ray screenings.
System which identifies patients at risk of fatal heart attack obtains CE mark.
Companies will shed light on immunotherapy, an emerging therapeutic approach that helps the immune system fight cancer, in a brand-new study on one of the most impacting cancers worldwide.
The system uses heatmaps to make AI decisions transparent to clinicians.